chr1-21841723-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005529.7(HSPG2):c.9194-50G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.647 in 1,609,232 control chromosomes in the GnomAD database, including 338,829 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.62 ( 29305 hom., cov: 32)
Exomes 𝑓: 0.65 ( 309524 hom. )
Consequence
HSPG2
NM_005529.7 intron
NM_005529.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.104
Publications
15 publications found
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
- Schwartz-Jampel syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Silverman-Handmaker type dyssegmental dysplasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- Schwartz-Jampel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 1-21841723-C-T is Benign according to our data. Variant chr1-21841723-C-T is described in ClinVar as [Benign]. Clinvar id is 1231634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.798 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.616 AC: 93525AN: 151872Hom.: 29274 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
93525
AN:
151872
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.652 AC: 161199AN: 247280 AF XY: 0.653 show subpopulations
GnomAD2 exomes
AF:
AC:
161199
AN:
247280
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.650 AC: 947649AN: 1457242Hom.: 309524 Cov.: 34 AF XY: 0.650 AC XY: 471097AN XY: 724932 show subpopulations
GnomAD4 exome
AF:
AC:
947649
AN:
1457242
Hom.:
Cov.:
34
AF XY:
AC XY:
471097
AN XY:
724932
show subpopulations
African (AFR)
AF:
AC:
16774
AN:
33396
American (AMR)
AF:
AC:
27289
AN:
44416
Ashkenazi Jewish (ASJ)
AF:
AC:
18784
AN:
26122
East Asian (EAS)
AF:
AC:
33112
AN:
39664
South Asian (SAS)
AF:
AC:
51116
AN:
85950
European-Finnish (FIN)
AF:
AC:
36271
AN:
52958
Middle Eastern (MID)
AF:
AC:
3513
AN:
5238
European-Non Finnish (NFE)
AF:
AC:
721323
AN:
1109264
Other (OTH)
AF:
AC:
39467
AN:
60234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
19224
38449
57673
76898
96122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.616 AC: 93610AN: 151990Hom.: 29305 Cov.: 32 AF XY: 0.619 AC XY: 45946AN XY: 74282 show subpopulations
GnomAD4 genome
AF:
AC:
93610
AN:
151990
Hom.:
Cov.:
32
AF XY:
AC XY:
45946
AN XY:
74282
show subpopulations
African (AFR)
AF:
AC:
20953
AN:
41426
American (AMR)
AF:
AC:
9063
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
2543
AN:
3472
East Asian (EAS)
AF:
AC:
4225
AN:
5158
South Asian (SAS)
AF:
AC:
2939
AN:
4806
European-Finnish (FIN)
AF:
AC:
7324
AN:
10572
Middle Eastern (MID)
AF:
AC:
208
AN:
294
European-Non Finnish (NFE)
AF:
AC:
44607
AN:
67952
Other (OTH)
AF:
AC:
1323
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1839
3678
5516
7355
9194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2548
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.